Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In studies of FDA-approved semaglutide at 2.4mg weekly (Wegovy), participants experienced average weight reductions of approximately 15% over 68 weeks when combined with diet and exercise
If you're unsure which option is right for you, discuss your symptoms, medical history, and lab results with your healthcare provider before beginning supplementation
Multi-dose compounded tirzepatide vials with preservatives are typically limited to 28 days after first use, though you must follow the specific beyond-use date provided by your compounding pharmacy
Ewing GE
Less than 3% of clinical trial participants experienced persistent diarrhea beyond week 16, and most of those found it manageable enough to continue treatment
Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: An investigator-initiated, placebo-controlled, double-blind, parallel-group
US$ 22.35
US$ 27.53
US$ 26.54
US$ 23.93
